Cargando…
Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492825/ https://www.ncbi.nlm.nih.gov/pubmed/34626857 http://dx.doi.org/10.1016/j.jaip.2021.09.039 |
| _version_ | 1784578999664508928 |
|---|---|
| author | Ieven, Toon Van Weyenbergh, Thomas Vandebotermet, Martijn Devolder, David Breynaert, Christine Schrijvers, Rik |
| author_facet | Ieven, Toon Van Weyenbergh, Thomas Vandebotermet, Martijn Devolder, David Breynaert, Christine Schrijvers, Rik |
| author_sort | Ieven, Toon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8492825 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84928252021-10-06 Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients Ieven, Toon Van Weyenbergh, Thomas Vandebotermet, Martijn Devolder, David Breynaert, Christine Schrijvers, Rik J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2021-12 2021-10-06 /pmc/articles/PMC8492825/ /pubmed/34626857 http://dx.doi.org/10.1016/j.jaip.2021.09.039 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Clinical Communications Ieven, Toon Van Weyenbergh, Thomas Vandebotermet, Martijn Devolder, David Breynaert, Christine Schrijvers, Rik Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients |
| title | Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients |
| title_full | Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients |
| title_fullStr | Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients |
| title_full_unstemmed | Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients |
| title_short | Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients |
| title_sort | tolerability of polysorbate 80–containing covid-19 vaccines in confirmed polyethylene glycol–allergic patients |
| topic | Clinical Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492825/ https://www.ncbi.nlm.nih.gov/pubmed/34626857 http://dx.doi.org/10.1016/j.jaip.2021.09.039 |
| work_keys_str_mv | AT ieventoon tolerabilityofpolysorbate80containingcovid19vaccinesinconfirmedpolyethyleneglycolallergicpatients AT vanweyenberghthomas tolerabilityofpolysorbate80containingcovid19vaccinesinconfirmedpolyethyleneglycolallergicpatients AT vandebotermetmartijn tolerabilityofpolysorbate80containingcovid19vaccinesinconfirmedpolyethyleneglycolallergicpatients AT devolderdavid tolerabilityofpolysorbate80containingcovid19vaccinesinconfirmedpolyethyleneglycolallergicpatients AT breynaertchristine tolerabilityofpolysorbate80containingcovid19vaccinesinconfirmedpolyethyleneglycolallergicpatients AT schrijversrik tolerabilityofpolysorbate80containingcovid19vaccinesinconfirmedpolyethyleneglycolallergicpatients |